Disclaimer: The captions in this video are auto-generated and may contain inaccuracies.
Professor Angus Dalgleish
Professor Angus Dalgleish, M.D., F.R.C.P., F.R.A.C.P., F.R.C.Path, F.Med.Sci is a renowned oncologist practicing in the United Kingdom, who splits his time between clinical patient care and research. Prof. Dalgleish serves as an advisor to a number of biopharmaceutical companies and is a principal investigator in several clinical trials. Prof. Dalgleish has been a Professor of Medical Oncology at St George’s University of London and Consultant Physician at St George’s Hospital since 1991. He has served as the President of the Clinical Immunology and Allergy Section of the Royal Society of Medicine. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists.
Prof. Dalgleish studied Medicine at University College London, where he obtained an MBBS and a BSc in Anatomy. Among his main interests are: immunology and melanoma, use of anti-angiogenic agents & low dose chemotherapy in resistant solid tumor disease of the prostate, colon & breast. A clinical researcher of international repute, he has made significant contributions to the study of the immunological basis of AIDS and to the field of cancer vaccines. He is the current Principal of the Cancer Vaccine Institute.
To view his bio, click on Prof. Angus Dalgleish’s profile
To view his published articles, click on Prof. Angus Dalgleish’s Work
Copied from: https://www.ldnscience.org/ldn/ldn-researchers/angus-dalgleish
Doctor Paul Marik
Prior to co-founding the FLCCC, Dr. Marik was best known for his revolutionary work in developing a lifesaving protocol for sepsis, a condition that causes more than 250,000 deaths yearly in the U.S. alone.
Dr. Marik is an accomplished physician with special knowledge in a diverse set of medical fields, with specific training in Internal Medicine, Critical Care, Neurocritical Care, Pharmacology, Anesthesia, Nutrition, and Tropical Medicine and Hygiene. He is a former tenured Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School (EVMS) in Norfolk, Virginia. As part of his commitment to research and education, Dr. Marik has written over 500 peer-reviewed journal articles, 80 book chapters and authored four critical care books and the Cancer Care Monograph. His efforts have provided him with the distinction of the second most published critical care physician in the world. He has been cited over 54,500 times in peer-reviewed publications and has an H-index of 111. He has delivered over 350 lectures at international conferences and visiting professorships. As a result of his contributions, he has been the recipient of numerous teaching awards, including the National Teacher of the Year award by the American College of Physicians in 2017.
In January 2022 Dr. Marik retired from EVMS to focus on continuing his leadership of the FLCCC and has already co-authored over 10 papers on therapeutic aspects of treating COVID-19. In March 2022 Dr. Marik received a commendation by unanimous vote by the Virginia House of Delegates for “his courageous treatment of critically ill COVID-19 patients and his philanthropic efforts to share his effective treatment protocols with physicians around the world.”
Copied from: https://covid19criticalcare.com/experts/paul-e-marik/
Dr Jeyanthi Kunadhasan
Is an anesthetist and perioperative physician from Victoria, Australia.
She has been in medical leadership at her previous hospital as well as statewide; as chair of the Medical Senior Group representing consultant doctors,
as well as a previous chair of the Advisory Committee of Blood Matters Victoria.
Her clinical interest is Patient Blood Management, where she spearheaded many initiatives that sustainably brought down the unnecessary transfusion rates in major surgeries, leading to improved patient outcomes and lower costs to the health system.
In December 2021, when vaccine mandates were rolled out, Dr. Kunadhasan requested a risk assessment. Her goal in doing so was to warn her employer at the time about the risks of the shots, while at the same time trying to keep her job and avoid taking the injection herself. Unfortunately, instead of taking a pause and considering Dr. Kunadhasan’s request, in December 2021, Dr. Kunadhasan was fired by her employer.
She is currently the treasurer of the Australian Medical Professionals Society (AMPS).
Dr. Kunadhasan is also the lead author on “Report 42, Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA” and subsequently wrote two articles in Spectator Australia, explaining her findings in the Pfizer documents.
Copied from: https://wowintl.org/jeyanthi-kunadhasan
Leave a Reply
Want to join the discussion?Feel free to contribute!
Using your first name